Salesforce (CRM) insider Parker Harris reports major option exercise and stock sales
Rhea-AI Filing Summary
Salesforce, Inc. director and officer Parker Harris, Co-Founder and CTO of Slack, reported exercising and selling company stock on 12/02/2025. He exercised 134,662 non-qualified stock options at an exercise price of $161.50 per share, converting them into Salesforce common stock. That same day, he reported multiple open-market sales of Salesforce common stock totaling the same 134,662 shares at weighted average prices ranging from about $231.93 to $236.58, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 17, 2024. After these transactions, he reported 139,767 shares held directly and additional indirect ownership through the HJ Family Trust and several LLCs managed by him and his spouse.
Positive
- None.
Negative
- None.
Insights
Analyzing...
FAQ
What insider transaction did Salesforce (CRM) report for Parker Harris?
Parker Harris reported exercising 134,662 stock options at $161.50 per share and selling the resulting Salesforce common shares in multiple transactions on 12/02/2025.
At what prices did Parker Harris sell Salesforce (CRM) shares on 12/02/2025?
He reported weighted average sale prices ranging from about $231.93 to $236.58 per share, with sales broken into several price ranges disclosed in the footnotes.
Was the Salesforce (CRM) insider sale by Parker Harris under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected automatically under a Rule 10b5-1 trading plan adopted by Parker Harris on December 17, 2024.
How many Salesforce (CRM) shares does Parker Harris own after the reported transactions?
After the transactions, he reported 139,767 shares owned directly, plus additional shares held indirectly through the HJ Family Trust and several LLCs managed by him and his spouse.
What type of derivative security did Parker Harris exercise in this Salesforce (CRM) Form 4?
He exercised a non-qualified stock option to buy 134,662 Salesforce common shares at an exercise price of $161.50 per share, originally granted with vesting over four years starting March 22, 2020.